Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Misoprostol-is more research needed?

Mary Lou Moore1

  • 1M ary L ou M oore is an associate professor in the Department of Obstetrics and Gynecology at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

The Journal of Perinatal Education
|February 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Celiac disease and preterm and/or low birthweight births.

MCN. The American journal of maternal child nursing·2013
Same author

A model of recovering medical errors in the coronary care unit.

Heart & lung : the journal of critical care·2008
Same author

Follow-up care for infants with chronic lung disease: a randomized comparison of community- and center-based models.

Pediatrics·2007
Same author

Complementary and alternative therapies.

The Journal of perinatal education·2007
Same author

Reducing the rate of cesarean birth.

The Journal of perinatal education·2007
Same author

Preterm birth: a continuing challenge.

The Journal of perinatal education·2007

Misoprostol, a synthetic prostaglandin E1 analogue, is widely used off-label in obstetrics despite risks like uterine rupture. Further research is needed to confirm if its benefits, such as reduced C-sections, outweigh potential dangers.

Area of Science:

  • Pharmacology
  • Obstetrics & Gynecology
  • Reproductive Medicine

Background:

  • Misoprostol is a synthetic prostaglandin E1 analogue.
  • Originally developed for peptic ulcers, it is widely used off-label in obstetrics.
  • Its use is not approved by the Food and Drug Administration (FDA).

Purpose of the Study:

  • To review the obstetric applications of misoprostol.
  • To outline the advantages and disadvantages of its use in obstetrics.
  • To emphasize the need for informed consent and further research.

Main Methods:

  • Literature review of misoprostol's obstetric uses.
  • Analysis of cited advantages and disadvantages.
  • Discussion of current clinical practice and research needs.

Related Experiment Videos

Main Results:

  • Misoprostol is used for first/second trimester abortion, labor induction, and postpartum hemorrhage control.
  • Cited advantages include reduced C-section rates, shorter labor, low cost, and ease of administration/storage.
  • Disadvantages include uterine hyperstimulation, rupture, and maternal death.

Conclusions:

  • Misoprostol offers potential benefits in obstetric care but carries significant risks.
  • Informed consent regarding risks and benefits is crucial for patients.
  • Large-scale research is required to definitively assess the risk-benefit profile.